Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Side effects are intolerable at your current dose
10.1016/S0014-5793(03)00727-0 FEBS Lett
Eligibility criteria include specific BMI thresholds, presence of comorbidities such as type 2 diabetes or cardiovascular disease, and previous weight loss attempts
Log everything that passes your lips into a nutritional calculator for 2 weeks
Consult with healthcare providers about whether GLP-1 medications are appropriate for your individual health needs, particularly if you have thyroid conditions
collapse Signs of sepsis: high fever or very low temperature, rapid breathing, confusion, or feeling extremely unwell following an injection Severe hypoglycaemia with loss of consciousness or inability to swallow Severe chest pain or significant difficulty breathing Contact your GP or a healthcare professional promptly if you experience: Injection site reactions such as persistent redness, swelling, warmth, or pain, which may indicate infection or an inflammatory response Systemic symptoms including fever, chills, or malaise following administration Gastrointestinal symptoms such as severe or persistent nausea, vomiting, or abdominal pain these are known effects associated with GLP-1 receptor agonism and may require clinical assessment [15] [6] Symptoms of hypoglycaemia shakiness, sweating, confusion, or palpitations particularly if retatrutide is being used alongside other glucose-lowering agents Cardiovascular symptoms such as a rapid or irregular heartbeat Report suspected side effects via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk
US$ 25.57
US$ 24.50
US$ 21.88
US$ 22.12
US$ 22.53
US$ 28.94
